The company aims to further develop the areas of artificial intelligence and computer-protected chemistry with a focus on biotechnology and information technology. The company is involved in research, consulting, molecular simulations and machine learning to support the process of drug development. To this end, it promotes scientific exchange and organizes symposia in Switzerland and abroad. The company can establish branches in Switzerland and abroad, participate in other companies in Switzerland and abroad, acquire similar or related companies or merge with them, acquire, manage and sell real estate, and enter into all transactions and conclude contracts that are suitable to promote the purpose of the company or are directly or indirectly related to it.